Abxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, and Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NASDAQ: AMRX), today announced that the U.S.

Approvals expand Amneal’s biosimilars portfolioCompany expects to commercialize six biosimilars across eight presentations by 2027 BRIDGEWATER, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Amneal ...

Approvals expand Amneal's biosimilars portfolioCompany expects to commercialize six biosimilars across eight presentations by 2027 BRIDGEWATER, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceu ...

Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...

Tramadol, a popular opioid often seen as a “safer” painkiller, may not live up to its reputation. A large analysis of ...

Trodelvy showed fewer severe side effects, such as neutropenia and diarrhea, compared to chemotherapy in untreated TNBC ...

Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...

Oral corticosteroids present significant long-term risks with uncertain evidence for improving asthma outcomes, according to data presented at the American College of Allergy, Asthma & Immunology ...

Fish oil is generally safe but can cause side effects such as bad breath, diarrhea, unpleasant aftertaste, heartburn, and reduced immune function.

Different blood sugar medications can cause different side effects. Learn more about some of the serious possible side effects of common diabetes medications here.

Lexaria says its oral GLP-1 cut total adverse events nearly 48% versus Novo's Rybelsus, with comparable HbA1c results in a Phase 1b study.

Nearly half of all adults in the U.S. have high blood pressure, or hypertension, according to the CDC. One of the most common ...